Find a Professional

Find a Professional

340B ESP

BRG’s proprietary methodology for scrubbing ineligible rebates attributable to 340B purchasing

340B ESPTM, BRG’s proprietary methodology for scrubbing ineligible rebates attributable to 340B purchasing, helps enable manufacturers to better identify duplicate commercial discounts. Whether rebates are processed by a third party or a custom solution developed by a manufacturer, 340B ESPTM integrates seamlessly and helps enable on-invoice or retrospective analysis to identify 340B purchased drugs and avoid payment of duplicate discounts.

Duplicate Commercial Discounts on the Rise

Duplicate commercial discounts, which exceeded $2 billion in 2018, are on the rise in part due to entrenched trends

How BRG Can Help

Most manufacturers today have developed a process for identifying outpatient pharmacies that predominantly dispense 340B purchased drugs. However, this approach does not address the fastest-growing segment of 340B: contract pharmacies. BRG professionals have developed a proprietary process for pinpointing those rebates originating from third-party contract pharmacies. 340B ESPTM enhances manufacturers’ existing scrubbing processes and can in some cases result in a two- to threefold increase in scrubbed rebates.

Ready to Get Started?

Find out how piloting 340B ESPTM can help better assess your duplicate discount risk and prove the concept for your organization: 340BSolutions@thinkbrg.com